Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is a peripheral opioid receptor agonist presented as an oral tablet for oral use. It reduces intestinal motility and fluid secretion, providing symptomatic relief for acute nonspecific diarrhea, chronic diarrhea and traveler's diarrhea in adults and children when indicated. The product is available over‑the‑counter in the European Union and is used under medical guidance.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Imodium (loperamide) acts on the gastrointestinal motility pathway to manage diarrheal conditions.

Acute nonspecific diarrhea: reduces stool frequency and improves consistency in short‑term episodes. Chronic diarrhea: provides symptomatic control for ongoing diarrheal disorders such as IBS‑D. Traveler’s diarrhea: offers rapid relief for diarrhea acquired during travel.

Common Side Effects: - Constipation: reduced bowel movements may become infrequent. - Nausea: mild stomach upset may occur. - Abdominal cramps: occasional discomfort in the abdomen. - Dizziness: transient light‑headedness reported by some users. - Dry mouth: reduced salivation. - Headache: mild tension‑type headache.

Serious or Rare Side Effects: - Severe constipation or bowel obstruction: risk of impaction requiring medical attention. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, pruritus, or angioedema. - Cardiac arrhythmias: QT prolongation in susceptible individuals. - Severe abdominal pain: may indicate obstruction. - Ileus: paralytic bowel requiring intervention.

Imodium should be used with caution and according to label or prescriber instructions.

Do not exceed recommended dose: follow label or prescriber guidance. Avoid use in bacterial enterocolitis: may worsen infection. Use with caution in hepatic impairment: reduced drug clearance. Avoid in children under 2 years: higher risk of serious side effects. Pregnancy and breastfeeding: consult a healthcare professional before use. Store at room temperature: keep in the original pack, protect from moisture and heat.

Loperamide may interact with several medicines; awareness of interaction severity helps ensure safe use.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase loperamide plasma levels. - P‑gp inhibitors (e.g., quinidine, verapamil): raise systemic exposure. - Opioid analgesics: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may intensify constipation. - Antidiarrheal combination therapy: risk of excessive slowing of gut motility. - Diuretics: may enhance dehydration risk.